Inactive Instrument
Pressure BioSciences, Inc. Stock Nasdaq
Stocks
US74112E1091
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Market Cap | 143K 124K 116K 106K 201K 13.68M 204K 1.36M 535K 6.81M 538K 527K 22.57M | P/E 2022 |
-0.81x | P/E 2023 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 22.95M 19.91M 18.53M 17.02M 32.17M 2.19B 32.69M 218M 85.69M 1.09B 86.18M 84.29M 3.61B | EV / Sales 2022 |
21.1x | EV / Sales 2023 | 15.5x |
| Free-Float |
99.27% | Yield 2022 * |
-
| Yield 2023 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 16/04/2004 | |
| Chief Tech/Sci/R&D Officer | 61 | 03/04/2006 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 72 | 24/04/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 01/01/1992 | |
Jeffrey Peterson
CHM | Chairman | 70 | 08/08/2012 |
Michael Urdea
BRD | Director/Board Member | 73 | 08/02/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.43% | +1.06% | +22.80% | +4.67% | 213B | |
| -0.61% | +1.82% | -1.11% | -23.56% | 137B | |
| +0.10% | +4.69% | -26.56% | +8.92% | 125B | |
| +1.59% | +5.60% | -55.46% | -9.87% | 69.46B | |
| -0.98% | +4.16% | +8.52% | +4.87% | 49.56B | |
| -0.91% | +5.13% | -22.07% | -30.22% | 47.2B | |
| -0.25% | -0.14% | +20.52% | +13.63% | 39.08B | |
| -0.79% | +0.70% | +30.67% | +36.60% | 37.05B | |
| -2.75% | +12.28% | -4.63% | -12.79% | 30.72B | |
| Average | -0.56% | +3.87% | -3.03% | -0.86% | 83.15B | |
| Weighted average by Cap. | -0.36% | +3.04% | -1.71% | -1.99% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.73M 1.5M 1.4M 1.28M 2.42M 165M 2.46M 16.44M 6.46M 82.16M 6.49M 6.35M 272M | 1.98M 1.72M 1.6M 1.47M 2.77M 189M 2.82M 18.81M 7.38M 93.96M 7.43M 7.26M 311M |
| Net income | -16.08M -13.95M -12.98M -11.93M -22.53M -1.53B -22.9M -153M -60.03M -764M -60.37M -59.05M -2.53B | -29.31M -25.43M -23.67M -21.75M -41.09M -2.8B -41.75M -279M -109M -1.39B -110M -108M -4.61B |
| Net Debt | 20.53M 17.81M 16.57M 15.23M 28.77M 1.96B 29.23M 195M 76.64M 975M 77.08M 75.39M 3.23B | 22.8M 19.78M 18.41M 16.92M 31.97M 2.18B 32.48M 217M 85.15M 1.08B 85.64M 83.76M 3.59B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
